Brigitte Dréno
Brigitte Dréno is an expert in Dermatology at Centre Hospitalier Universitaire de Nantes (France). As of October 2026, ScienceLeadR ranks Brigitte Dréno in the top 1% of experts worldwide for Acneiform Eruptions, Acne Vulgaris and Sebaceous Gland Diseases. Brigitte Dréno has authored 1,250 publications, the most recent in 2026, and is an investigator in 49 clinical trials, 1 of them ongoing. SLR score: 4,309 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Oncology - Public Health - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1987 - 2026
Number : 1250
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study. PMID 42791653 — cells, merkel cells, somatostatin, neoplasms, therapeutics, dermatology, carcinoma, merkel cell | Cancer Med | 2026 | 0 |
| Integrating AI, RNA Vaccines, and CAR-T Cells for Personalized Treatment. PMID 42677342 — cells, vaccines, neoplasms, immune system diseases, therapeutics, artificial intelligence, receptors, antigen, t-cell, rna, car-t cell, mrna vaccines | J Immunol Res | 2026 | 0 |
| Real-World Use of Adjuvant Nivolumab for Resected Stage III-IV Melanoma: 2-Year Analysis of AdjuMel. PMID 42667537 — safety, melanoma, nivolumab, therapeutics | Dermatol Ther (Heidelb) | 2026 | 0 |
| The Role of Dermocosmetics in Acne Management: Implications for Clinical Practice in Brazil. PMID 42609585 — skin, skin care, treatment adherence and compliance, cosmeceuticals, dermatologic agents, therapeutics, education, patient education as topic, skin microbiome | Clin Cosmet Investig Dermatol | 2026 | 0 |
| A wake-up call for acne. PMID 42360703 — sexually transmitted diseases, skin diseases | J Eur Acad Dermatol Venereol | 2026 | 0 |
Clinical Studies 49
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West the COVER Cohort (Verneuil Cohort) NCT04352036 — phenotype, hidradenitis | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map